Ace inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 273, Issue 2 42-2, 1997, Pages

  Lear, William ^a   Ruzicka, Marcel ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Enalapril; Quinapril

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; MESSENGER RNA; PHOSPHOGLYCERATE KINASE; QUINAPRIL;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; ARTICLE; CONTROLLED STUDY; HEART VENTRICLE HYPERTROPHY; HEART VOLUME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 33751284988     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.273.2.h641     Document Type: Article

References (13)

1. Allan, D. R., J. A. McKnight, I. Kifor, C. M. Coletti, and N. K. Hollenberg. Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 24: 516-522, 1994.
2. Arvola, P., H. Ruskoaho, H. Wuorela, A. Pekki, H. Vapaatalo, and I. Porsti. Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats. Br. J. Pharmacol. 108: 980-990, 1993.
3. Baker, K. M., M. I. Chernin, S. K. Wixson, and J. F. Aceto. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am. J. Physiol. 259 (Heart Circ. Physiol. 38): H324-H332, 1990.
4. Boer, P. H., M. Ruzicka, W. Lear, E. Harmsen, J. Rosenthal, and F. H. H. Leenen. Stretch-mediated activation of cardiac renin gene. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H1630-H1636, 1994.
5. Chomczynski, P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Bio Techniques 15: 532-537, 1993.
6. Cushman, D. W., F. L. Wang, W. C. Fung, C. M. Harvey, and J. M. DeForrest. Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs. Am. J. Hypertens. 2: 294-306, 1989.
7. Garcia, R., and S. Diebold. Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc. Res. 24: 430-432, 1990.
8. Heymes, C., B. Swynghedauw, and B. Chevalier. Activation of angiotensinogen and angiotensin-converting enzyme gene expression in the left ventricle of senescent rats. Circulation 90: 1328-1333, 1994.
9. Hirsch, A. T., C. E. Talsness, H. Schunkert, M. Paul, and V. J. Dzau. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ. Res. 69: 475-482, 1991.
10. Hubert, C., A.-M. Houot, P. Corvol, and F. Soubrier. Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J. Biol. Chem. 266: 15377-15383, 1991.
11. Kinoshita, A., H. Urata, F. M. Bumpus, and A. Husain. Measurement of angiotensin I converting enzyme inhibition in the heart. Circ. Res. 73: 51-60, 1993.
12. Nakajima, T., T. Yamada, and M. Setoguchi. Prolonged inhibition of local angiotensin-converting enzyme after single or repeated treatment with quinapril in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 19: 102-107, 1992.
13. Ruzicka, M., and F. H. H. Leenen. Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy. Circulation 91: 16-19, 1995.